Article

Current prices versus minimum costs of production for CFTR modulators

2022-01-31

Abstract excerpt

<h4>Background</h4> While the clinical benefits of CFTR modulators are clear, their high prices render them inaccessible outside of a select few countries. Despite this, there is currently limited evidence regarding access to these transformative therapies. Therefore, this study aims to estimate the minimum costs of production of CFTR modulators, assuming robust generic competition, and to compare them with curren...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 83dfc7e0-60fe-5172-b8cd-e69ca93ef20f
DOI: 10.1101/2022.01.29.22270088

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Current prices versus minimum costs of production for CFTR modulatorsDOI 10.1101/2022.01.29.22270088Read

Current prices versus minimum costs of production for CFTR modulators.Semantic proximity Read

Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosis.Semantic proximity Read

Ivacaftor for cystic fibrosis: An evaluation of real world utilisation and expenditure in the Irish Healthcare Setting.Semantic proximity Read

Estimated global cost of treating COVID-19, HIV, Hepatitis B and Hepatitis C with approved effective oral medicationsSemantic proximity Read

Estimated Costs of Production Compared with National Prices, for Drugs to Treat Clinical ObesitySemantic proximity Read

Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials.Semantic proximity Read

CFTR Lifecycle Map-A Systems Medicine Model of CFTR Maturation to Predict Possible Active Compound Combinations.Semantic proximity Read

Cost of Goods Sold Analysis for Manufacturing mRNA-Based Cell and Gene TherapiesSemantic proximity Read

How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access Ahead of Patent ExpirySemantic proximity Read

Differences in the cost of manufacturing pharmaceuticals in India for differently regulated markets: A comparative analysisSemantic proximity Read

Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis.Semantic proximity Read

A New Mechanism To Identify Cost Savings in NHS Prescribing: Minimising “Price-Per-Unit”Semantic proximity Read